(Q41032451)

25 September 2017

1 reference

title

Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections (English)

1 reference

25 September 2017

M Haria

1

1 reference

25 September 2017

H M Bryson

series ordinal

2

1 reference

25 September 2017

K L Goa

series ordinal

3

1 reference

25 September 2017

1 April 1996

1 reference

25 September 2017

1 reference

25 September 2017

51

1 reference

25 September 2017

4

1 reference

25 September 2017

585-620

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199651040-00006

25 September 2017

0 references

cites work

Superficial fungal infections of the skin. Diagnosis and current treatment recommendations

1 reference

12 December 2020

Pharmacokinetics of itraconazole following oral administration to normal volunteers

1 reference

12 December 2020

Itraconazole and anti-tuberculosis drugs

1 reference

12 December 2020

Onychomycosis caused by Microsporum canis: treatment with itraconazole

1 reference

12 December 2020

Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy

1 reference

12 December 2020

Treatment of onychomycosis: traditional approaches

1 reference

12 December 2020

Pharmacokinetic optimisation of oral antifungal therapy

1 reference

12 December 2020

Assay of itraconazole in nail clippings by reversed phase, high performance liquid chromatography

1 reference

12 December 2020

Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers

1 reference

12 December 2020

Itraconazole in tinea versicolor: a review

1 reference

12 December 2020

Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology)

1 reference

12 December 2020

Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris

1 reference

12 December 2020

Hepatotoxicity associated with itraconazole

1 reference

12 December 2020

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

1 reference

12 December 2020

Oral azole drugs as systemic antifungal therapy

1 reference

12 December 2020

Adrenal response to corticotropin during therapy with itraconazole

1 reference

12 December 2020

Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections

1 reference

12 December 2020

Itraconazole therapy in lymphangitic and cutaneous sporotrichosis.

1 reference

12 December 2020

Adverse drug reactions to systemic antifungals. Prevention and management

1 reference

12 December 2020

Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

1 reference

12 December 2020

Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective

1 reference

12 December 2020

A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group

1 reference

12 December 2020

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

1 reference

12 December 2020

Coadministration of rifampin and itraconazole leads to undetectable levels of serum itraconazole

1 reference

12 December 2020

Cutaneous leishmaniasis. Treatment with itraconazole

1 reference

12 December 2020

A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize

1 reference

12 December 2020

Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study

1 reference

12 December 2020

[Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital]

1 reference

12 December 2020

Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or tinea cruris

1 reference

12 December 2020

Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. German Collaborative Dermatophyte Drug Susceptibility Study Group

1 reference

12 December 2020

[Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine]

1 reference

12 December 2020

Interaction of itraconazole and digoxin

1 reference

12 December 2020

Itraconazole-induced acute hepatitis

1 reference

12 December 2020

Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents

1 reference

12 December 2020

Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin

1 reference

12 December 2020

Debilitating edema associated with itraconazole therapy

1 reference

12 December 2020

Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor

1 reference

12 December 2020

Itraconazole pharmacokinetics in patients with renal dysfunction

1 reference

12 December 2020

Itraconazole in the treatment of tinea capitis

1 reference

12 December 2020

Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis

1 reference

12 December 2020

Nomenclature of fungal diseases: a report and recommendations from a Sub-Committee of the International Society for Human and Animal Mycology (ISHAM).

1 reference

12 December 2020

Itraconazole-didanosine excipient interaction

1 reference

12 December 2020

The triazole antifungal agents: a review of itraconazole and fluconazole.

1 reference

12 December 2020

Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870.

1 reference

12 December 2020

Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study.

1 reference

12 December 2020

The clinical pharmacokinetics of itraconazole: an overview

1 reference

12 December 2020

Chronic or recurrent vaginal candidosis: short-term treatment and prophylaxis with itraconazole

1 reference

12 December 2020

Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.

1 reference

12 December 2020

Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum

1 reference

12 December 2020

Itraconazole and cyclosporin nephrotoxicity

1 reference

12 December 2020

Cutaneous Alternaria infection treated with itraconazole

1 reference

12 December 2020

Cyclosporine and itraconazole interaction in heart and lung transplant recipients

1 reference

12 December 2020

Degenerative changes in fungi after itraconazole treatment

1 reference

12 December 2020

Itraconazole: a single-day oral treatment for acute vulvovaginal candidosis

1 reference

12 December 2020

An evaluation of itraconazole in the management of onychomycosis

1 reference

12 December 2020

Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children

1 reference

12 December 2020

Digoxin toxicity associated with itraconazole therapy

1 reference

12 December 2020

The pharmacokinetics of oral itraconazole in AIDS patients

1 reference

12 December 2020

Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations

1 reference

12 December 2020

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

1 reference

12 December 2020

Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases

1 reference

12 December 2020

Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis

1 reference

12 December 2020

Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models

1 reference

12 December 2020

Current therapy of dermatophytosis.

1 reference

12 December 2020

Itraconazole in the treatment of tinea corporis and tinea cruris

1 reference

12 December 2020

A comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar-type tinea pedis.

1 reference

12 December 2020

Skin Kinetics of Azole Antifungal Drugs

1 reference

12 December 2020

Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections

1 reference

12 December 2020

Itraconazole: Precautions regarding drug interactions and bioavailability

1 reference

12 December 2020

In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents.

1 reference

12 December 2020

Antifungal agents: an overview. Part II.

1 reference

12 December 2020

Oral therapeutic agents in fungal nail disease

1 reference

12 December 2020

Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia

1 reference

12 December 2020

Itraconazole in the treatment of superficial mycoses--a double-blind study vs. placebo

1 reference

12 December 2020

In-vitro studies with SF 86-327, a new orally active allylamine derivative.

1 reference

12 December 2020

Protein binding of itraconazole and fluconazole in patients with cancer

1 reference

12 December 2020

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

1 reference

12 December 2020

Itraconazole in the treatment of dermatophytoses: a comparison of two daily dosages

1 reference

12 December 2020

Mechanisms and clinical impact of antifungal drug resistance.

1 reference

12 December 2020

Potentiation of action of warfarin by itraconazole

1 reference

12 December 2020

Itraconazole in the treatment of pityriasis versicolor: comparison between 5 and 7 days of treatment

1 reference

12 December 2020

Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses

1 reference

12 December 2020

Management of fungal skin infections with 15 days itraconazole treatment: a worldwide review

1 reference

12 December 2020

Onychomycosis Treated with Itraconazole or Griseofulvin Alone with and without a Topical Antimycotic or Keratolytic Agent

1 reference

12 December 2020

Vincristine toxicity in five children with acute lymphoblastic leukaemia

1 reference

12 December 2020

Cutaneous leishmaniasis in Kuwait. Clinical experience with itraconazole

1 reference

12 December 2020

A double-blind, randomized, stratified controlled study of the treatment of tinea imbricata with oral terbinafine or itraconazole

1 reference

12 December 2020

New approaches to the treatment of onychomycosis

1 reference

12 December 2020

Time course of cyclosporin/itraconazole interaction

1 reference

12 December 2020

[Comparative evaluation of fluconazole 50 mg and 100 mg versus itraconazole 100 mg in the treatment of dermatomycoses]

1 reference

12 December 2020

Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers

1 reference

12 December 2020

Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis

1 reference

12 December 2020

[Clinical and mycological studies of griseofulvin treated onychomycoses].

1 reference

12 December 2020

The effect of ketoconazole and itraconazole on the filamentous form of Pityrosporum ovale

1 reference

12 December 2020

Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.

1 reference

12 December 2020

Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party

1 reference

12 December 2020

Onychomycosis. Agents of choice.

1 reference

12 December 2020

Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis

1 reference

12 December 2020

Itraconazole in dermatophyte infections: clinical experience in Italy

1 reference

12 December 2020

Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity

1 reference

12 December 2020

Cutaneous cryptococcosis successfully treated with itraconazole

1 reference

12 December 2020

Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics

1 reference

12 December 2020

Mycetoma caused by Acremonium falciforme: successful treatment with itraconazole

1 reference

12 December 2020

Open randomized comparison of itraconazole versus terbinafine in onychomycosis

1 reference

12 December 2020

Antifungal susceptibility testing

1 reference

12 December 2020

Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine.

1 reference

12 December 2020

Plasma itraconazole concentrations in neutropenic patients after repeated high-dose treatment

1 reference

12 December 2020

Efficacy and safety of itraconazole in the long-term treatment of onychomycosis

1 reference

12 December 2020

The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica

1 reference

12 December 2020

Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis

1 reference

12 December 2020

Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole

1 reference

12 December 2020

Possible interaction between phenobarbital, carbamazepine and itraconazole

1 reference

12 December 2020

Itraconazole Compared with Griseofulvin in the Treatment of Tinea corporis/cruris and Tinea pedis/manus: An Interpretation of the Clinical Results of all Completed Double-Blind Studies with Respect to the Pharmacokinetic Profile

1 reference

12 December 2020

Improvement of eumycetoma with itraconazole

1 reference

12 December 2020

Hallucinations associated with itraconazole therapy

1 reference

12 December 2020

Successful treatment of chromoblastomycosis with itraconazole.

1 reference

12 December 2020

Subcutaneous phaeohyphomycosis caused by Exophiala jeanselmei: successful treatment with itraconazole

1 reference

12 December 2020

Digoxin-itraconazole interaction

1 reference

12 December 2020

Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis

1 reference

12 December 2020

Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia

1 reference

12 December 2020

Itraconazole in pityriasis versicolor

1 reference

12 December 2020

The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis

1 reference

12 December 2020

Itraconazole therapy in pityriasis versicolor

1 reference

12 December 2020

Treatment of human cutaneous sporotrichosis with itraconazole

1 reference

12 December 2020

Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards

1 reference

12 December 2020

A case of chromoblastomycosis responding to treatment with itraconazole

1 reference

12 December 2020

Treatment of dermatophytosis with new systemic antifungal agent, itraconazole

1 reference

12 December 2020

Fungal morphology after treatment with itraconazole as a single oral dose in experimental vaginal candidosis in rats

1 reference

12 December 2020

Pityriasis versicolor: efficacy of two five-day regimens of itraconazole.

1 reference

12 December 2020

Pregnancy associated with a combined oral contraceptive and itraconazole

1 reference

12 December 2020

Itraconazole in onychomycosis. Open and double-blind studies

1 reference

12 December 2020

Clinical manifestations of onychomycosis

1 reference

12 December 2020

Interaction between itraconazole and digoxin

1 reference

12 December 2020

Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole

1 reference

12 December 2020

Cutaneous protothecosis treated with itraconazole

1 reference

12 December 2020

A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study

1 reference

12 December 2020

Interaction of cyclosporin and itraconazole

1 reference

12 December 2020

Localized cutaneous cryptococcosis successfully treated with itraconazole. Review of medication in 18 cases reported in Japan

1 reference

12 December 2020

Itraconazole-Digoxin Interaction

1 reference

12 December 2020

Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group

1 reference

12 December 2020

Quality of life of persons with onychomycosis.

1 reference

12 December 2020

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

12 December 2020

Ventricular fibrillation secondary to itraconazole induced hypokalaemia

1 reference

12 December 2020

Oral itraconazole versus topical bifonazole treatment in experimental dermatophytosis

1 reference

12 December 2020

Azole drug resistance in yeasts

1 reference

12 December 2020

Itraconazole-induced acute generalized exanthemic pustulosis

1 reference

12 December 2020

A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus

1 reference

12 December 2020

Pharmacokinetic profile of orally administered itraconazole in human skin

1 reference

12 December 2020

Developments in hyalohyphomycosis and phaeohyphomycosis.

1 reference

12 December 2020

Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration

1 reference

12 December 2020

Fluconazole versus itraconazole in the treatment of tinea versicolor

1 reference

12 December 2020

Itraconazole in the treatment of acute vaginal candidosis

1 reference

12 December 2020

Mycological and clinical evaluation of griseofulvin for chronic onychomycosis

1 reference

12 December 2020

Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae

1 reference

12 December 2020

Can we prevent azole resistance in fungi?

1 reference

12 December 2020

Successful treatment of Aspergillus flavus onychomycosis with oral itraconazole

1 reference

12 December 2020

Cutaneous phaeohyphomycosis due to Alternaria alternata responding to itraconazole

1 reference

12 December 2020

Interaction of Azoles with Rifampin, Phenytoin, and Carbamazepine: In Vitro and Clinical Observations

1 reference

12 December 2020

Resistance to antifungal agents

1 reference

12 December 2020

Itraconazole: a new triazole antifungal agent

1 reference

12 December 2020

Risk/benefit ratio of modern antifungal therapy: focus on hepatic reactions

1 reference

12 December 2020

Adverse events associated with itraconazole in 189 patients on chronic therapy.

1 reference

12 December 2020

Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients

1 reference

12 December 2020

Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences

1 reference

12 December 2020

Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation

1 reference

12 December 2020

[Liver damage during administration of itraconazole (Trisporal)]

1 reference

12 December 2020

Cutaneous leishmaniasis in India. Clinical experience with itraconazole (R51 211 Janssen).

1 reference

12 December 2020

Preliminary clinical study of the use of itraconazole in the treatment of vulvovaginal candidiasis

1 reference

12 December 2020

Itraconazole penetrates the nail via the nail matrix and the nail bed--an investigation in onychomycosis

1 reference

12 December 2020

Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers

1 reference

12 December 2020

Protein binding of itraconazole and fluconazole in patients with chronic renal failure

1 reference

12 December 2020

Tinea pedis (mocassin-type) treated with itraconazole

1 reference

12 December 2020

Itraconazole interacts with felodipine

1 reference

12 December 2020

Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations

1 reference

12 December 2020

Vertigo and hypokalemia. Two rare side effects of itraconazole

1 reference

12 December 2020

Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses

1 reference

12 December 2020

Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris

1 reference

12 December 2020

Treatment of dermatomycoses and onychomycoses--state of the art

1 reference

12 December 2020

Itraconazole in pityriasis versicolor: ultrastructural changes in Malassezia furfur produced during treatment

1 reference

12 December 2020

10.2165/00003495-199651040-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

25 September 2017

0 references

1 reference